Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Avastin Biosimilar market was valued at US$ 1379.8 million in 2022 and is projected to reach US$ 484.9 million by 2029, at a CAGR of -13.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
400mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Avastin Biosimilar include Celltrion, Amneal, Pfizer and Amgen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Avastin Biosimilar is a humanized monoclonal antibody. It inhibits angiogenesis (the formation of new blood vessels) by blocking the action of vascular endothelial growth factor A (VEGF-A). Bevacizumab can therefore slow the growth of new blood vessels in tumours and is used to treat various cancers, including colorectal, lung, breast, glioblastoma, kidney and ovarian.
This report aims to provide a comprehensive presentation of the global market for Avastin Biosimilar, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Avastin Biosimilar. This report contains market size and forecasts of Avastin Biosimilar in global, including the following market information:
Global Avastin Biosimilar Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Avastin Biosimilar Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Avastin Biosimilar companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Avastin Biosimilar manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Avastin Biosimilar Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Avastin Biosimilar Market Segment Percentages, by Type, 2022 (%)
400mg
100mg
Global Avastin Biosimilar Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Avastin Biosimilar Market Segment Percentages, by Application, 2022 (%)
Cancer
Wet Age-related Macular Degeneration
Other
Global Avastin Biosimilar Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Avastin Biosimilar Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Avastin Biosimilar revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Avastin Biosimilar revenues share in global market, 2022 (%)
Key companies Avastin Biosimilar sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Avastin Biosimilar sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Celltrion
Amneal
Pfizer
Amgen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Avastin Biosimilar, market overview.
Chapter 2: Global Avastin Biosimilar market size in revenue and volume.
Chapter 3: Detailed analysis of Avastin Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Avastin Biosimilar in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Avastin Biosimilar capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Avastin Biosimilar Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Avastin Biosimilar Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Avastin Biosimilar Overall Market Size
2.1 Global Avastin Biosimilar Market Size: 2022 VS 2029
2.2 Global Avastin Biosimilar Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Avastin Biosimilar Sales: 2018-2029
3 Company Landscape
3.1 Top Avastin Biosimilar Players in Global Market
3.2 Top Global Avastin Biosimilar Companies Ranked by Revenue
3.3 Global Avastin Biosimilar Revenue by Companies
3.4 Global Avastin Biosimilar Sales by Companies
3.5 Global Avastin Biosimilar Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Avastin Biosimilar Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Avastin Biosimilar Product Type
3.8 Tier 1, Tier 2 and Tier 3 Avastin Biosimilar Players in Global Market
3.8.1 List of Global Tier 1 Avastin Biosimilar Companies
3.8.2 List of Global Tier 2 and Tier 3 Avastin Biosimilar Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Avastin Biosimilar Market Size Markets, 2022 & 2029
4.1.2 400mg
4.1.3 100mg
4.2 By Type - Global Avastin Biosimilar Revenue & Forecasts
4.2.1 By Type - Global Avastin Biosimilar Revenue, 2018-2023
4.2.2 By Type - Global Avastin Biosimilar Revenue, 2024-2029
4.2.3 By Type - Global Avastin Biosimilar Revenue Market Share, 2018-2029
4.3 By Type - Global Avastin Biosimilar Sales & Forecasts
4.3.1 By Type - Global Avastin Biosimilar Sales, 2018-2023
4.3.2 By Type - Global Avastin Biosimilar Sales, 2024-2029
4.3.3 By Type - Global Avastin Biosimilar Sales Market Share, 2018-2029
4.4 By Type - Global Avastin Biosimilar Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Avastin Biosimilar Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Wet Age-related Macular Degeneration
5.1.4 Other
5.2 By Application - Global Avastin Biosimilar Revenue & Forecasts
5.2.1 By Application - Global Avastin Biosimilar Revenue, 2018-2023
5.2.2 By Application - Global Avastin Biosimilar Revenue, 2024-2029
5.2.3 By Application - Global Avastin Biosimilar Revenue Market Share, 2018-2029
5.3 By Application - Global Avastin Biosimilar Sales & Forecasts
5.3.1 By Application - Global Avastin Biosimilar Sales, 2018-2023
5.3.2 By Application - Global Avastin Biosimilar Sales, 2024-2029
5.3.3 By Application - Global Avastin Biosimilar Sales Market Share, 2018-2029
5.4 By Application - Global Avastin Biosimilar Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Avastin Biosimilar Market Size, 2022 & 2029
6.2 By Region - Global Avastin Biosimilar Revenue & Forecasts
6.2.1 By Region - Global Avastin Biosimilar Revenue, 2018-2023
6.2.2 By Region - Global Avastin Biosimilar Revenue, 2024-2029
6.2.3 By Region - Global Avastin Biosimilar Revenue Market Share, 2018-2029
6.3 By Region - Global Avastin Biosimilar Sales & Forecasts
6.3.1 By Region - Global Avastin Biosimilar Sales, 2018-2023
6.3.2 By Region - Global Avastin Biosimilar Sales, 2024-2029
6.3.3 By Region - Global Avastin Biosimilar Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Avastin Biosimilar Revenue, 2018-2029
6.4.2 By Country - North America Avastin Biosimilar Sales, 2018-2029
6.4.3 US Avastin Biosimilar Market Size, 2018-2029
6.4.4 Canada Avastin Biosimilar Market Size, 2018-2029
6.4.5 Mexico Avastin Biosimilar Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Avastin Biosimilar Revenue, 2018-2029
6.5.2 By Country - Europe Avastin Biosimilar Sales, 2018-2029
6.5.3 Germany Avastin Biosimilar Market Size, 2018-2029
6.5.4 France Avastin Biosimilar Market Size, 2018-2029
6.5.5 U.K. Avastin Biosimilar Market Size, 2018-2029
6.5.6 Italy Avastin Biosimilar Market Size, 2018-2029
6.5.7 Russia Avastin Biosimilar Market Size, 2018-2029
6.5.8 Nordic Countries Avastin Biosimilar Market Size, 2018-2029
6.5.9 Benelux Avastin Biosimilar Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Avastin Biosimilar Revenue, 2018-2029
6.6.2 By Region - Asia Avastin Biosimilar Sales, 2018-2029
6.6.3 China Avastin Biosimilar Market Size, 2018-2029
6.6.4 Japan Avastin Biosimilar Market Size, 2018-2029
6.6.5 South Korea Avastin Biosimilar Market Size, 2018-2029
6.6.6 Southeast Asia Avastin Biosimilar Market Size, 2018-2029
6.6.7 India Avastin Biosimilar Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Avastin Biosimilar Revenue, 2018-2029
6.7.2 By Country - South America Avastin Biosimilar Sales, 2018-2029
6.7.3 Brazil Avastin Biosimilar Market Size, 2018-2029
6.7.4 Argentina Avastin Biosimilar Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Avastin Biosimilar Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Avastin Biosimilar Sales, 2018-2029
6.8.3 Turkey Avastin Biosimilar Market Size, 2018-2029
6.8.4 Israel Avastin Biosimilar Market Size, 2018-2029
6.8.5 Saudi Arabia Avastin Biosimilar Market Size, 2018-2029
6.8.6 UAE Avastin Biosimilar Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Celltrion
7.1.1 Celltrion Company Summary
7.1.2 Celltrion Business Overview
7.1.3 Celltrion Avastin Biosimilar Major Product Offerings
7.1.4 Celltrion Avastin Biosimilar Sales and Revenue in Global (2018-2023)
7.1.5 Celltrion Key News & Latest Developments
7.2 Amneal
7.2.1 Amneal Company Summary
7.2.2 Amneal Business Overview
7.2.3 Amneal Avastin Biosimilar Major Product Offerings
7.2.4 Amneal Avastin Biosimilar Sales and Revenue in Global (2018-2023)
7.2.5 Amneal Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Avastin Biosimilar Major Product Offerings
7.3.4 Pfizer Avastin Biosimilar Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Amgen
7.4.1 Amgen Company Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Avastin Biosimilar Major Product Offerings
7.4.4 Amgen Avastin Biosimilar Sales and Revenue in Global (2018-2023)
7.4.5 Amgen Key News & Latest Developments
8 Global Avastin Biosimilar Production Capacity, Analysis
8.1 Global Avastin Biosimilar Production Capacity, 2018-2029
8.2 Avastin Biosimilar Production Capacity of Key Manufacturers in Global Market
8.3 Global Avastin Biosimilar Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Avastin Biosimilar Supply Chain Analysis
10.1 Avastin Biosimilar Industry Value Chain
10.2 Avastin Biosimilar Upstream Market
10.3 Avastin Biosimilar Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Avastin Biosimilar Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
